Investigational Site Number: 3480003
Budapest 1125
2 studies enrolling now · 14 studies all time
What they study most
Breast Cancer Metastatic, Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Multiple Sclerosis, Non-small Cell Lung Cancer Metastatic, Pancreatic Carcinoma Metastatic, Plasma Cell Myeloma, Psoriasis, Sjogren's Syndrome, Sjögren's Syndrome, T-cell Type Acute Leukemia-Precursor, T-lymphoblastic Lymphoma/Leukaemia
Studies at this site
- A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Recruiting now
- A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis — Recruiting now
- SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients — Stopped early
- Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
- Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients — Completed
- Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
- A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis — Completed
- Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) — Completed
- Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors — Stopped early
- Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients — Completed
- Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed
- Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia — Stopped early
- Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early
- A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps — Completed